Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Stock
Equities
300760
CNE100003G67
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 181.37 CNY | +2.93% |
|
-2.45% | -4.77% |
| Capitalization | 219B 31.81B 27.42B 24.75B 23.75B 43.31B 2,923B 45.33B 293B 117B 1,402B 119B 117B 5,013B | P/E ratio 2025 * |
22.9x | P/E ratio 2026 * | 20x |
|---|---|---|---|---|---|
| Enterprise value | 199B 28.84B 24.86B 22.44B 21.53B 39.27B 2,650B 41.1B 265B 106B 1,271B 108B 106B 4,545B | EV / Sales 2025 * |
5.81x | EV / Sales 2026 * | 5.16x |
| Free-Float |
42.59% | Yield 2025 * |
2.89% | Yield 2026 * | 3.2% |
| 1 day | +2.93% | ||
| 1 week | -2.45% | ||
| Current month | -2.45% | ||
| 1 month | -4.29% | ||
| 3 months | -10.39% | ||
| 6 months | -23.78% | ||
| Current year | -4.77% |
| 1 week | 175.5 |  | 186.01 |
| 1 month | 175.5 | | 191 |
| Current year | 175.5 | | 214.12 |
| 1 year | 175.5 | | 257 |
| 3 years | 175.5 | | 351.6 |
| 5 years | 175.5 | | 502 |
| 10 years | 58.56 | | 503.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Wu
CEO | Chief Executive Officer | 54 | 2020-11-16 |
Yun Zhao
DFI | Director of Finance/CFO | 43 | 2019-11-14 |
Yan Mei Guo
PRN | Corporate Officer/Principal | 63 | 2021-04-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Hang Xu
CHM | Chairman | 64 | 1999-01-24 |
Xi Ting Li
CHM | Chairman | 75 | 2001-12-17 |
Ming He Cheng
BRD | Director/Board Member | 65 | 2017-01-04 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.93% | -2.45% | -25.69% | -41.11% | 31.81B | |
| -3.25% | -3.67% | -5.59% | -8.54% | 186B | |
| -1.32% | -2.65% | -5.42% | +112.46% | 174B | |
| -3.22% | -7.19% | -7.81% | -20.29% | 138B | |
| -2.25% | -7.16% | -28.02% | +51.74% | 106B | |
| -0.22% | -4.11% | -22.85% | -20.33% | 52.29B | |
| -2.68% | -5.59% | +16.08% | +3.45% | 47.42B | |
| -0.96% | -1.32% | +8.79% | +17.60% | 36.67B | |
| -3.68% | -11.87% | -14.22% | -2.60% | 33.85B | |
| -2.57% | -5.20% | -9.18% | -18.00% | 32.52B | |
| Average | -1.72% | -3.96% | -9.39% | +7.44% | 83.92B | |
| Weighted average by Cap. | -2.15% | -3.88% | -9.22% | +21.95% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 34.21B 4.96B 4.28B 3.86B 3.7B 6.76B 456B 7.07B 45.64B 18.29B 219B 18.62B 18.22B 782B | 37.92B 5.5B 4.74B 4.28B 4.11B 7.49B 505B 7.84B 50.59B 20.27B 242B 20.63B 20.19B 867B |
| Net income | 9.6B 1.39B 1.2B 1.08B 1.04B 1.9B 128B 1.98B 12.81B 5.13B 61.35B 5.22B 5.11B 219B | 10.98B 1.59B 1.37B 1.24B 1.19B 2.17B 146B 2.27B 14.65B 5.87B 70.16B 5.97B 5.85B 251B |
| Net Debt | -20.48B -2.97B -2.56B -2.31B -2.22B -4.04B -273B -4.23B -27.33B -10.95B -131B -11.15B -10.91B -468B | -23.87B -3.46B -2.98B -2.69B -2.59B -4.71B -318B -4.93B -31.85B -12.76B -153B -12.99B -12.72B -546B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-06 | 181.37 ¥ | +2.93% | 7,638,494 |
| 26-03-05 | 176.20 ¥ | +0.26% | 5,098,138 |
| 26-03-04 | 175.75 ¥ | -2.58% | 8,835,447 |
| 26-03-03 | 180.40 ¥ | -1.80% | 8,567,185 |
| 26-03-02 | 183.70 ¥ | -1.19% | 8,620,961 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300760 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition